临沂微信上400块3小时-临沂微信上400块3小时_第1页

在河源酒店晚上怎么叫服务



Tel: 020-28269507

News Center

News

Center

Industry news

Great news! African swine fever vaccine took the lead in Xinjiang, Heilongjiang


March Wei Hongyang, deputy director of the animal husbandry and Veterinary Bureau of the Ministry of agriculture and rural areas, said at a press conference held by the State Council on the joint prevention and control mechanism, At present, we have received the application of some units to carry out clinical trials. We are organizing experts to guide these application units, improve the clinical trial scheme, and strive to carry out the clinical trial work as soon as possible.


Wei Hongyang said that vaccines belong to a very special kind of commodity. Only when the three principles of safety, effectiveness and quality are controllable, and there is scientific and detailed data support, can it be approved to be listed as a commodity and used in the industry. Therefore, on this issue, we should say that we are also happy to see its success, but we should not rush for it.
Wei Hongyang said that African swine fever vaccine research is a worldwide problem. So far, no country in the world, including our country, has approved any commercial application vaccine. After the outbreak of African swine fever, the Ministry of agriculture and rural areas and other relevant departments actively supported and encouraged legal and compliant scientific research institutions to strengthen the research and development of African swine fever vaccine. According to the information we have, at present, different institutions have made some positive progress. At the same time, some units have applied to the Ministry of agriculture and rural areas to carry out clinical trials. We have received this application and are organizing experts to guide these application units to complete the clinical trial scheme and strive to carry out clinical trial work as soon as possible.

Wei Hongyang said that in the future, I think we should still adhere to two principles: first, high standards, that is, the three standards of safety, effectiveness and controllable quality should not be lowered. The second is to strive for high efficiency. We will improve the efficiency of examination and approval and speed up the work of examination and approval at the later stage.